EUVIMEDEUVIMED entdecken
Crossref

Genome Reduction Improves Recombinant Benzoxazole Production in Myxococcus xanthus

Dustin Joshua Vollmann, Lucia Lernoud, Markus Nett iD

ACS Synthetic Biology · 16.05.2025 · 14 (5) · 1756-1765

DOI: 10.1021/acssynbio.5c00114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 21.04.2025. Verfasst von Dustin Joshua Vollmann und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical and Chemical Engineering, TU Dortmund University, Dortmund 44227, Germany. Hauptthemen laut MEDLINE: Myxococcus xanthus, Genome, Bacterial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome reduction is a fundamental concept in evolution. In synthetic biology, the same strategy has been adopted for the construction of cells with desired physiological and metabolic traits. In this study we report the impact of genome reduction on the biotechnological performance of Myxococcus xanthus. This predatory soil bacterium is a model system for coordinated social behavior, which ranges from cooperative feeding to the formation of fruiting bodies. The complexity of its lifestyle is reflected in a large genome, of which a significant portion harbors biosynthetic gene clusters (BGCs) for the production of secondary metabolites. These compounds are typically considered dispensable for growth under defined laboratory conditions. Therefore, the genomic deletion of these BGCs was expected to eliminate metabolic byproducts and to liberate biosynthetic resources, which could then be supplied to recombinant pathways. Our studies show that the consecutive removal of BGCs from the M. xanthus genome can considerably improve the titer of a recombinantly produced natural product. Furthermore, we observed that M. xanthus does not tolerate the combined elimination of certain BGCs, whereas individual deletions of the same loci are possible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myxococcus xanthusGenome, BacterialMultigene FamilyMetabolic EngineeringSynthetic BiologyBiosynthetic Pathways

Stichwörter der Autor:innen

Myxococcus xanthusbenzoxazolegenome reductionheterologous expressionnatural products

Autor:innen und Institutionen

  • Department of Biochemical and Chemical Engineering, TU Dortmund University, Dortmund 44227, Germany.

ORCID-Profile: Markus Nett

Zitieren

APA

Vollmann, D. J., Lernoud, L., & Nett, M. (2025). Genome Reduction Improves Recombinant Benzoxazole Production in Myxococcus xanthus. ACS Synthetic Biology, 14(5), 1756-1765. https://doi.org/10.1021/acssynbio.5c00114

Vancouver

Vollmann DJ, Lernoud L, Nett M. Genome Reduction Improves Recombinant Benzoxazole Production in Myxococcus xanthus. ACS Synthetic Biology. 2025;14(5):1756-1765. doi:10.1021/acssynbio.5c00114

BibTeX
@article{Vollmann2025,
  author = {Vollmann, Dustin Joshua and Lernoud, Lucia and Nett, Markus},
  title = {Genome Reduction Improves Recombinant Benzoxazole Production in Myxococcus xanthus},
  journal = {ACS Synthetic Biology},
  year = {2025},
  volume = {14},
  number = {5},
  pages = {1756--1765},
  doi = {10.1021/acssynbio.5c00114}
}
Kostenlos starten →